- Report
- July 2022
- 461 Pages
Global
From €4811EUR$5,457USD£3,950GBP
- Report
- December 2023
- 315 Pages
Global
From €4811EUR$5,457USD£3,950GBP
- Report
- December 2022
- 437 Pages
Global
From €4811EUR$5,457USD£3,950GBP
- Report
- October 2022
- 213 Pages
Global
From €4811EUR$5,457USD£3,950GBP
From €300EUR$352USD£264GBP
From €300EUR$352USD£264GBP
From €300EUR$352USD£264GBP
From €300EUR$352USD£264GBP
From €300EUR$352USD£264GBP
From €400EUR$470USD£352GBP
From €300EUR$352USD£264GBP
- Report
- March 2025
- 84 Pages
Global
From €400EUR$470USD£352GBP
- Report
- June 2023
- 60 Pages
Global
From €3148EUR$3,450USD£2,675GBP
- Report
- April 2023
- 35 Pages
China
From €4517EUR$4,950USD£3,838GBP
- Report
- November 2023
- 124 Pages
Global
From €4106EUR$4,500USD£3,489GBP
- Report
- June 2022
- 89 Pages
Global
From €1460EUR$1,600USD£1,241GBP
- Report
- February 2024
- 202 Pages
Global
From €4563EUR$5,000USD£3,877GBP
- Report
- October 2022
- 194 Pages
Global
From €4563EUR$5,000USD£3,877GBP
- Report
- August 2022
- 180 Pages
Global
From €5475EUR$6,000USD£4,652GBP
- Report
- November 2020
- 217 Pages
Global
From €3650EUR$4,000USD£3,101GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more